Entrada Therapeutics (TRDA) Non-Current Assets (2020 - 2026)
Entrada Therapeutics (TRDA) recorded Non-Current Assets of $66.17 million in Q2 2026, down 16.9% from $79.64 million a year earlier and down 3.6% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics reported Non-Current Assets of $71.13 million, down 17.6% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 81.8% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $86.28 million in FY2024 (-13.2%), $99.42 million in FY2023 (+135.7%), $42.18 million in FY2022 (+491.4%) and $7.13 million in FY2021 (+99.4%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2023.
- On a year-over-year basis, Non-Current Assets has declined for nine consecutive quarters, with an average decline of 15.2% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 491.4% in Q4 2022, against a decline of 17.6% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $68.65 million (Q1 2026), $71.13 million (Q4 2025) and $74.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Entrada Therapeutics | 242.19 Mn | 242.19 Mn | - | 66.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.17 Mn |
| Mar 31, 2026 | 68.65 Mn |
| Dec 31, 2025 | 71.13 Mn |
| Sep 30, 2025 | 74.64 Mn |
| Jun 30, 2025 | 79.64 Mn |
| Mar 31, 2025 | 83.29 Mn |
| Dec 31, 2024 | 86.28 Mn |
| Sep 30, 2024 | 89.26 Mn |
| Jun 30, 2024 | 92.43 Mn |
| Mar 31, 2024 | 96.67 Mn |
| Dec 31, 2023 | 99.42 Mn |
| Sep 30, 2023 | 101.99 Mn |
| Jun 30, 2023 | 103.79 Mn |
| Mar 31, 2023 | 41.43 Mn |
| Dec 31, 2022 | 42.18 Mn |
| Sep 30, 2022 | 39.73 Mn |
| Jun 30, 2022 | 42.01 Mn |
| Mar 31, 2022 | 43.99 Mn |
| Dec 31, 2021 | 7.13 Mn |
| Sep 30, 2021 | 8.87 Mn |
API Access
Entrada Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();